CELL CRYOPRESERVATION MARKET ANALYSIS

Cell Cryopreservation Market Size and Trends

Global cell cryopreservation market is estimated to be valued at USD 10.10 Bn in 2024 and is expected to reach USD 43.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 23% from 2024 to 2031.

To learn more about this report, request sample copy

Growing prevalence of chronic diseases coupled with rising investments in R&D of regenerative medicine can drive the global cell cryopreservation market growth.The market is witnessing various innovations that aid in commercialization and uptake of cell cryopreservation technologies. There has been an increased focus on developing techniques that can better preserve cell viability and functionality post-thaw. Cryopreservation of stem cells and genetically modified cells can offer opportunities for applications in drug discovery, personalized medicine and disease modeling over the forecast period.

Growing demand for stem cell research

Global cell cryopreservation market is expected to witness growth due to rising demand for stem cell research activities. Stem cells are used in developing new treatments for chronic and life-threatening diseases like cancer, diabetes, cardiac ailments and neurodegenerative conditions. Cryopreservation plays a crucial role in stem cell research as it allows viable storage and transportation of stem cells for extended periods of time. Researchers are continuously working on utilizing the unique capabilities of stem cells such as differentiation and regeneration for developing cell-based and targeted therapies. Significant investments are being made by both public and private players to advance stem cell science. For instance, the National Institutes of Health in the U.S. allocated millions of dollars funding for stem cell initiatives. Several biopharma companies have also ramped up their R&D efforts focused on stem cell therapies. With the progress of stem cell research, the requirements from cell cryopreservation expands in terms of higher sample volumes, more robust infrastructure and stricter regulatory compliances. Researchers need reliable preservation of different types of stem cells over extended durations for various applications ranging from basic research to clinical translation. For instance, in January 2024, a stem cell therapy created by UC Davis Health researchers demonstrated encouraging results in preclinical trials for treating Crohn’s disease.

Advancements in regenerative medicine

Technological advancements in the field of regenerative medicine can drive the market growth. Regenerative therapies aim to repair or replace damaged cells, tissues and organs through stimulating the body's innate healing response. Some key areas witnessing ground-breaking progress include tissue engineering, organ engineering and development of artificial organs. Several clinical trials are exploring the application of tissues grown from cryopreserved cell sources such as skin, bone marrow and heart valves for reconstructive procedures. Emerging field of 3D bioprinting also relies on cryopreserved cell viability for printing transplantable organs and implantable tissues. For example, scientists have successfully 3D printed heart patches, liver tissue and bone structures using living cells.